Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
New Gold Opportunities in the Cariboo Region (CSE:GCC) (OTC:GCCFF) (click to learn more) Why Herbal Dispatch (CSE:HERB) Is Getting Attention (click to learn more) Atlas Salt Expands MOU with Sandvik Mining Supporting Great Atlantic Salt Project (click to learn more) Digital Health Meets AI -CSE: ALEN.U (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Quoin Pharmaceuticals Ltd QNRX

Healthcare Biotechnology
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company’s lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:QNRX)

Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome

GlobeNewswire January 27, 2026

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome

GlobeNewswire January 20, 2026

Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies

GlobeNewswire November 11, 2025

Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results

GlobeNewswire November 6, 2025

Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025

GlobeNewswire October 30, 2025

Quoin Pharmaceuticals Announces Recruitment of Three Additional Patients in Investigator Pediatric Netherton Syndrome Study and Provides Positive 9 month 'Whole Body' Data Update from Ongoing Study

GlobeNewswire October 28, 2025

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

GlobeNewswire October 21, 2025

Quoin Pharmaceuticals Announces Private Placement Financing of Up to $104.5 Million

GlobeNewswire October 10, 2025

Quoin Pharmaceuticals Releases Fifth NETHERTON NOW Video Featuring Writers and Influencers Allie and Kaleigh Fasanella, Twin Sisters Living with Netherton Syndrome

GlobeNewswire September 9, 2025
View More News ››

Opinion & Analysis (NDAQ:QNRX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:QNRX)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - September 17, 2025

QNRX....sideways action til it isn't

Volume is too low.....outside chance of a last minute "heroics" I'd say it's range bound now....$6.66 low to $7.20...
Iseneschal - May 14, 2025

QNRX.... Dead cat bounce now??? LMFBO !

Go chit in a river.....14K / 5 min will get u no where....$7.10
Iseneschal - May 14, 2025

QNRX...I'd love to know for sure just how many Retail DT'ers

are stuck with the high priced paper trading the 1st 10 mins of the opening bell??? The hired assassins.... "The Pros" shorted...
Iseneschal - May 14, 2025

RE:Using technical analysis for this stock.

R u on the "Payroll" ??????
Iseneschal - May 14, 2025

QNRX....now read my lips !

Next announcement will be a P.O news release and the share price will tank  Just my 2 bits
Iseneschal - May 14, 2025
View more Bullboard ››

Nurcapital Common Stock

Nurcapital Common Stock

Nurcapital Corporation Ltd. is a Canada-based capital pool company. The Company is engaged in identifying and evaluating ...
View More »

Podcasts